Aterovax

PharmaceuticalsSeries AParis, Franceaterovax.com

Latest round

Series A

Last raised

Dec 2015

Total raised

$0.8M

Investors

3

About Aterovax

Aterovax SA is based in France and develops products for the diagnosis and treatment of atherosclerosis.

Who invested in Aterovax

3 investors across 1 round

See all investors in Aterovax

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Dec 2, 2015

    Amount

    $0.8M

    Investors

    Locked

Questions about Aterovax

Who invested in Aterovax?

Aterovax has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Aterovax raised?

Aterovax has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Aterovax last raise money?

Aterovax's most recent round on record is a Series A, in Dec 2015.

What does Aterovax do?

Aterovax SA is based in France and develops products for the diagnosis and treatment of atherosclerosis.

Where is Aterovax headquartered?

Aterovax is headquartered in Paris, France.

Which VCs invest in companies like Aterovax?

Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back pharmaceuticals companies at Aterovax's stage. Their profiles are linked below.

Raising like Aterovax? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.